Identifying the etiology: a systematic approach using delayed-enhancement cardiovascular magnetic resonance.

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Heart Failure Clinics

• Publication date

  2009-07-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.hfc.2009.02.009PMID 19564013PMCID PMC2704908
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Accuracy of gadolinium-enhanced cardiovascular magnetic resonance in the diagnosis of cardiac sarcoidosis

  2009cited by this paper
• The usefulness of delayed enhancement magnetic resonance imaging for diagnosis and evaluation of cardiac function in patients with cardiac sarcoidosis.

  2008cited by this paper
• Cardiovascular magnetic resonance signs of ischemia in hypertrophic cardiomyopathy.

  2008cited by this paper
• Journal of Cardiovascular Magnetic Resonance Open Access Delayed Contrast Enhancement Cardiac Magnetic Resonance Imaging in Trastuzumab Induced Cardiomyopathy

  2008cited by this paper
• [MR imaging in cardiac amyloidosis--morphology, function and late enhancement].

  2008cited by this paper
• Clinical, genetic, and cardiac magnetic resonance imaging findings in primary desminopathies.

  2008cited by this paper
• Late gadolinium enhancement: precursor to cardiomyopathy in Duchenne muscular dystrophy?

  2008cited by this paper
• Characterisation of peripartum cardiomyopathy by cardiac magnetic resonance imaging

  2008cited by this paper
• Detection of Myocardial Fibrosis in Systemic Sclerosis by Contrast-Enhanced Magnetic Resonance Imaging

  2008cited by this paper
• Myocardial scar detected by contrast-enhanced cardiac magnetic resonance imaging is associated with ventricular tachycardia in hypertrophic cardiomyopathy patients.

  2008cited by this paper
• Suspected chronic myocarditis at cardiac MR: diagnostic accuracy and association with immunohistologically detected inflammation and viral persistence.

  2008cited by this paper
• Variables associated with contrast-enhanced cardiovascular magnetic resonance in hypertrophic cardiomyopathy: clinical implications.

  2008cited by this paper
• Cardiac Magnetic Resonance Imaging with Pharmacological Stress Perfusion and Delayed Enhancement in Asymptomatic Patients with Systemic Sclerosis

  2008cited by this paper
• Differential diagnosis of suspected apical ballooning syndrome using contrast-enhanced magnetic resonance imaging.

  2008cited by this paper
• Cardiovascular magnetic resonance imaging detects cardiac involvement in Churg-Strauss syndrome.

  2008cited by this paper
• Myocardial tissue characterization in systemic lupus erythematosus: value of a comprehensive cardiovascular magnetic resonance approach

  2008cited by this paper
• Cardiovascular magnetic resonance in clinically suspected cardiac amyloidosis: noninvasive imaging compared to endomyocardial biopsy.

  2008cited by this paper
• Risk Factors for the Progression of Coronary Artery Calcification in Asymptomatic Subjects: Results From the Multi-Ethnic Study of Atherosclerosis (MESA)

  2007cited by this paper
• Pattern and distribution of myocardial fibrosis in systemic sclerosis: a delayed enhanced magnetic resonance imaging study.

  2007cited by this paper
• Myocardial delayed enhancement by magnetic resonance imaging in patients with muscular dystrophy.

  2007cited by this paper
• MR characterization of cardiac abnormalities in HIV+ individuals with increased BNP levels.

  2007cited by this paper
• Prevalence and correlates of septal delayed contrast enhancement in patients with pulmonary hypertension.

  2007cited by this paper
• Clinical features and usefulness of cardiac magnetic resonance imaging in assessing myocardial viability and prognosis in Takotsubo cardiomyopathy (transient left ventricular apical ballooning syndrome).

  2007cited by this paper
• Feasibility of diagnosing chronic myocarditis by endomyocardial biopsy

  2007cited by this paper
• [Clinical significance of late gadolinium enhancement on cardiovascular magnetic resonance in patients with hypertrophic cardiomyopathy].

  2007cited by this paper
• Usefulness of delayed enhancement magnetic resonance imaging to differentiate dilated phase of hypertrophic cardiomyopathy and dilated cardiomyopathy.

  2007cited by this paper
• Significado clínico del realce tardío de gadolinio con resonancia magnética en pacientes con miocardiopatía hipertrófica

  2007cited by this paper
• Mid-myocardial fibrosis by cardiac magnetic resonance in patients with lamin A/C cardiomyopathy: possible substrate for diastolic dysfunction.

  2007cited by this paper
• Value of MRI in patients with a clinical suspicion of acute myocarditis

  2007cited by this paper
• Magnetic Resonance Imaging of Delayed Enhancement in Hypertrophic Cardiomyopathy: Relationship with Left Ventricular Perfusion and Contractile Function

  2006cited by this paper
• Delayed hyperenhancement in magnetic resonance imaging of left ventricular hypertrophy caused by aortic stenosis and hypertrophic cardiomyopathy: visualisation of focal fibrosis

  2006cited by this paper
• Redefinition of uremic cardiomyopathy by contrast-enhanced cardiac magnetic resonance imaging.

  2006cited by this paper
• Contemporary definitions and classification of the cardiomyopathies: an American Heart Association Scientific Statement from the Council on Clinical Cardiology, Heart Failure and Transplantation Committee; Quality of Care and Outcomes Research and Functional Genomics and Translational Biology Interd

  2006cited by this paper
• Impact of enzyme replacement therapy on cardiac morphology and function and late enhancement in Fabry's cardiomyopathy.

  2006cited by this paper
• Impact of enzyme replacement therapy on cardiac morphology and function and late enhancement in Fabry's cardiomyopathy.

  2006cited by this paper
• The histological basis of late gadolinium enhancement cardiovascular magnetic resonance in a patient with Anderson-Fabry disease.

  2006cited by this paper
• Effects of time, dose, and inversion time for acute myocardial infarct size measurements based on magnetic resonance imaging-delayed contrast enhancement.

  2006cited by this paper
• Presentation, Patterns of Myocardial Damage, and Clinical Course of Viral Myocarditis

  2006cited by this paper
• Cardiovascular magnetic resonance, fibrosis, and prognosis in dilated cardiomyopathy.

  2006cited by this paper
• Identification of the ischemic etiology of heart failure by cardiovascular magnetic resonance imaging: diagnostic accuracy of late gadolinium enhancement.

  2006cited by this paper
• Delayed enhancement cardiovascular magnetic resonance assessment of non-ischaemic cardiomyopathies.

  2005cited by this paper
• Noninvasive diagnosis of coronary artery disease in patients with heart failure and systolic dysfunction of uncertain etiology, using late gadolinium-enhanced cardiovascular magnetic resonance.

  2005cited by this paper
• Non-invasive evaluation of the myocardial substrate of cardiac amyloidosis by gadolinium cardiac magnetic resonance

  2005cited by this paper
• Cardiovascular Magnetic Resonance in Cardiac Amyloidosis

  2005cited by this paper
• Myocardial delayed enhancement by magnetic resonance imaging in patients with Chagas' disease: a marker of disease severity.

  2005cited by this paper
• The variation of morphological and functional cardiac manifestation in Fabry disease: potential implications for the time course of the disease.

  2005cited by this paper
• Effectiveness of delayed enhanced MRI for identification of cardiac sarcoidosis: comparison with radionuclide imaging.

  2005cited by this paper
• Differentiating acute myocardial infarction from myocarditis: diagnostic value of early- and delayed-perfusion cardiac MR imaging.

  2005cited by this paper
• Myocardial late gadolinium enhancement cardiovascular magnetic resonance in hypertrophic cardiomyopathy caused by mutations in troponin I

  2005cited by this paper
• Delayed contrast enhancement of MRI in hypertrophic cardiomyopathy.

  2004cited by this paper
• Cardiovascular Magnetic Resonance Assessment of Human Myocarditis: A Comparison to Histology and Molecular Pathology

  2004cited by this paper
• The histologic basis of late gadolinium enhancement cardiovascular magnetic resonance in hypertrophic cardiomyopathy.

  2004cited by this paper
• Noninvasive diagnosis of biopsy-proven cardiac amyloidosis.

  2004cited by this paper
• Delayed contrast enhancement of MRI in hypertrophic cardiomyopathy.

  2004cited by this paper
• Delayed hyper‐enhancement of myocardium in hypertrophic cardiomyopathy with asymmetrical septal hypertrophy: Comparison with global and regional cardiac MR imaging appearances

  2004cited by this paper
• Gadolinium Cardiovascular Magnetic Resonance Predicts Reversible Myocardial Dysfunction and Remodeling in Patients With Heart Failure Undergoing &bgr;-Blocker Therapy

  2003cited by this paper
• Intravascular Ultrasound Analysis of Infarct‐Related and Non‐Infarct‐Related Arteries in Patients Who Presented With an Acute Myocardial Infarction

  2003cited by this paper
• How we perform delayed enhancement imaging.

  2003cited by this paper
• Gadolinium enhanced cardiovascular magnetic resonance in Anderson-Fabry disease. Evidence for a disease specific abnormality of the myocardial interstitium.

  2003cited by this paper
• Toward clinical risk assessment in hypertrophic cardiomyopathy with gadolinium cardiovascular magnetic resonance.

  2003cited by this paper
• Differentiation of Heart Failure Related to Dilated Cardiomyopathy and Coronary Artery Disease Using Gadolinium‐Enhanced Cardiovascular Magnetic Resonance

  2003cited by this paper
• Gadolinium-enhanced magnetic resonance imaging in hypertrophic cardiomyopathy: in vivo imaging of the pathologic substrate for premature cardiac death?

  2003cited by this paper
• Myocardial Magnetic Resonance Imaging Contrast Agent Concentrations After Reversible and Irreversible Ischemic Injury

  2002cited by this paper
• Magnetic resonance imaging of myocardial fibrosis in hypertrophic cardiomyopathy.

  2002cited by this paper
• A standardized definition of ischemic cardiomyopathy for use in clinical research.

  2002cited by this paper
• Myocardial scarring in asymptomatic or mildly symptomatic patients with hypertrophic cardiomyopathy.

  2002cited by this paper
• Visualization of Discrete Microinfarction After Percutaneous Coronary Intervention Associated With Mild Creatine Kinase-MB Elevation

  2001cited by this paper
• An improved MR imaging technique for the visualization of myocardial infarction.

  2001cited by this paper
• Effect of carvedilol on survival in severe chronic heart failure.

  2001cited by this paper
• World Wide Web at:

  2001cited by this paper
• Visualisation of presence, location, and transmural extent of healed Q-wave and non-Q-wave myocardial infarction.

  2001cited by this paper
• Diagnosis of cardiac sarcoidosis and evaluation of the effects of steroid therapy by gadolinium-DTPA-enhanced magnetic resonance imaging.

  2001cited by this paper
• Acute coronary findings at autopsy in heart failure patients with sudden death: results from the assessment of treatment with lisinopril and survival (ATLAS) trial.

  2000cited by this paper
• Comparison of left ventricular ejection fraction and volumes in heart failure by echocardiography, radionuclide ventriculography and cardiovascular magnetic resonance; are they interchangeable?

  2000cited by this paper
• Reduction in sample size for studies of remodeling in heart failure by the use of cardiovascular magnetic resonance.

  2000cited by this paper
• Recognition of the importance of embolization in atherosclerotic vascular disease.

  2000cited by this paper
• The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction.

  2000cited by this paper
• Underlying causes and long-term survival in patients with initially unexplained cardiomyopathy.

  2000cited by this paper
• Relationship of MRI delayed contrast enhancement to irreversible injury, infarct age, and contractile function.

  1999cited by this paper
• Mechanisms of plaque rupture: mechanical and biologic interactions.

  1999cited by this paper
• Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the Definition and Classification of cardiomyopathies.

  1996cited by this paper
• Gross and semiquantitative histologic findings in mononuclear cell myocarditis causing sudden death, and implications for endomyocardial biopsy.

  1993cited by this paper
• Utility of various radionuclide techniques for distinguishing ischemic from nonischemic dilated cardiomyopathy.

  1992cited by this paper
• Clinical magnetic resonance imaging

  1990cited by this paper
• Evaluation of postmortem endomyocardial biopsy specimens from 38 patients with lymphocytic myocarditis: implications for role of sampling error.

  1989cited by this paper
• Idiopathic dilated cardiomyopathy: analysis of 152 necropsy patients.

  1987cited by this paper
• Relaxation of water protons in the intra‐ and extracellular regions of blood containing Gd(DTPA)

  1986cited by this paper
• Segmental wall motion abnormalities in dilated cardiomyopathy: a common finding and good prognostic sign.

  1984cited by this paper
• Results of coronary artery surgery in patients with poor left ventricular function (CASS).

  1983cited by this paper
• Ischemic cardiomyopathy: a clinicopathologic study of fourteen patients.

  1980cited by this paper
• Cardiomyopathic syndrome caused by coronary artery disease. III: Prospective clinicopathological study of its prevalence among patients with clinically unexplained chronic heart failure.

  1979cited by this paper
• The Wavefront Phenomenon of Ischemic Cell Death: 1. Myocardial Infarct Size vs Duration of Coronary Occlusion in Dogs

  1977cited by this paper
• Extracellular space and ionic distribution in rat ventricle.

  1974cited by this paper
• Echocardiographic Features of Congestive Cardiomyopathy Compared with Normal Subjects and Patients with Coronary Artery Disease

  1974cited by this paper
• Journal of Cardiovascular Magnetic Resonance Open Access Cardiac Involvement in Patients with Becker Muscular Dystrophy: New Diagnostic and Pathophysiological Insights by a Cmr Approach

  year unknowncited by this paper

• Cardiovascular Computed Tomography and Magnetic Resonance Imaging Guideline of the Brazilian Society of Cardiology and the Brazilian College of Radiology - 2024.

  2024cites this paper
• Nonischemic or Dual Cardiomyopathy in Patients With Coronary Artery Disease

  2023cites this paper
• Cardiac Magnetic Resonance, Electromechanical Activation, Kidney Function, and Natriuretic Peptides in Cardiac Resynchronization Therapy Upgrades

  2023cites this paper
• The Primary Cardiomyopathy of Systemic Sclerosis on Cardiovascular Magnetic Resonance Imaging.

  2023cites this paper
• Quantitative assessment of radiotherapy-induced myocardial damage using MRI: a systematic review

  2023cites this paper
• Recurrent ventricular tachycardia associated with lipomatous metaplasia of a myocardial scar

  2021cites this paper
• Tachy-Induced Cardiomyopathy: Pathophysiology, Diagnosis and Treatment

  2021cites this paper
• Myocardial damage assessed by late gadolinium enhancement on cardiovascular magnetic resonance imaging in cancer patients treated with anthracyclines and/or trastuzumab.

  2020cites this paper
• Cardiac MRI utilizing late gadolinium enhancement (LGE) and T1 mapping in the detection of radiation induced heart disease

  2020cites this paper
• Cardiac Magnetic Resonance in Nonischemic Cardiomyopathies.

  2020cites this paper
• Left ventricular thrombus on cardiovascular magnetic resonance imaging in non-ischaemic cardiomyopathy.

  2020cites this paper
• Cardiovascular Magnetic Resonance Imaging

  2019cites this paper
• Identifying nonischemic cardiomyopathy patients who would benefit from an implantable cardioverter-defibrillator: Can late gadolinium enhancement on cardiovascular magnetic resonance imaging help?

  2019cites this paper
• Chest Pain and a Very Abnormal Stress Echocardiogram.

  2018cites this paper
• Impact of Cardiovascular Magnetic Resonance Imaging on Identifying the Etiology of Cardiomyopathy in Patients Undergoing Cardiac Transplantation

  2018cites this paper
• Cancer Treatment-Related Cardiotoxicity: Role of Cardiovascular Magnetic Resonance Imaging

  2018cites this paper
• Functional CT Imaging for Myocardial Salvage in Acute Myocardial Infarction Management

  2018cites this paper
• Screening and Monitoring for Cardiotoxicity During Cancer Treatment

  2017cites this paper
• Coronary artery disease detection - limitations of stress testing in left ventricular dysfunction

  2017cites this paper
• Accuracy of left ventricular ejection fraction by contemporary multiple gated acquisition scanning in patients with cancer: comparison with cardiovascular magnetic resonance

  2017cites this paper
• Korean Guidelines for Diagnosis and Management of Chronic Heart Failure

  2017cites this paper
• Left Ventricular Long-Axis Function Assessed with Cardiac Cine MR Imaging Is an Independent Predictor of All-Cause Mortality in Patients with Reduced Ejection Fraction: A Multicenter Study.

  2017cites this paper
• The Use of Cardiac Magnetic Resonance in Patients with Suspected Coronary Artery Disease: A Clinical Practice Perspective

  2016cites this paper
• Magnetic Resonance Imaging Before and After CABG

  2016cites this paper
• Concordant and Discordant Cardiac Magnetic Resonance Imaging Delayed Hyperenhancement Patterns in Patients with Ischemic and Non-Ischemic Cardiomyopathy

  2016cites this paper
• Stress Cardiac MRI in Women With Myocardial Infarction and Nonobstructive Coronary Artery Disease

  2016cites this paper
• Etiology-specific assessment of predictors of long-term survival in chronic systolic heart failure

  2015cites this paper
• Cardiac Magnetic Resonance Scar Imaging for Sudden Cardiac Death Risk Stratification in Patients with Non-Ischemic Cardiomyopathy

  2015cites this paper
• Cardiovascular MR imaging in cardio-oncology.

  2015cites this paper
• Cardiac MRI Improves Identification of Etiology of Acute Ischemic Stroke

  2014cites this paper
• Etiologic Diagnosis of Cardiomyopathy in Heart Transplant recipients. agreement Between Pretransplant Clinical Diagnosis and Pathology

  2014cites this paper
• Systematic review and modelling of the cost-effectiveness of cardiac magnetic resonance imaging compared with current existing testing pathways in ischaemic cardiomyopathy.

  2014cites this paper
• Diagnóstico etiológico de la miocardiopatía en pacientes receptores de trasplante cardíaco: Concordancia entre el diagnóstico clínico pretrasplante y la anatomía patológica

  2014cites this paper
• Impact of cardiovascular magnetic resonance on management and clinical decision-making in heart failure patients

  2013cites this paper
• Practice guidelines for the diagnosis and management of systolic heart failure in low- and middle-income countries.

  2013cites this paper
• Late Gadolinium Enhancement CMR in Patients with Tachycardia‐Induced Cardiomyopathy Caused by Idiopathic Ventricular Arrhythmias

  2012cites this paper
• Heart failure in patients with normal coronary anatomy: diagnostic algorithm and disease pattern of various etiologies as defined by cardiac MRI.

  2012cites this paper
• Role of Magnetic Resonance Imaging in Electrophysiology

  2012cites this paper
• Multicenter Study Ventricular Ejection Fraction and Myocardial Damage : An International , Prognostic Value of Routine Cardiac Magnetic Resonance Assessment of Left

  2011cites this paper
• Ischemic heart disease: comprehensive evaluation by cardiovascular magnetic resonance.

  2011cites this paper
• The Role of Cardiac MR in New-Onset Heart Failure

  2011cites this paper
• Role of multimodality imaging in ischemic and non-ischemic cardiomyopathy

  2011cites this paper
• Die Rolle der Kardio-MRT bei Diagnose und Prognosebeurteilung der Herzinsuffizienz

  2011cites this paper
• Mechanisms of Myocardial Infarction in Women Without Angiographically Obstructive Coronary Artery Disease

  2011cites this paper
• Prognostic Value of Routine Cardiac Magnetic Resonance Assessment of Left Ventricular Ejection Fraction and Myocardial Damage: An International, Multicenter Study

  2011cites this paper
• Tachycardia-induced cardiomyopathy: evaluation and therapeutic options.

  2010cites this paper
• Use of cardiac magnetic resonance imaging to evaluate cardiac structure, function and fibrosis in children with infantile Pompe disease on enzyme replacement therapy.

  2010cites this paper
• Basic Principles of Magnetic Resonance Imaging Magnetic Field and Gradient Coil System

  2010cites this paper
• Tachycardia-Induced Cardiomyopathy : Evaluation and Therapeutic Options

  2010cites this paper
• Cardiovascular magnetic resonance in patients with myocardial infarction: current and emerging applications.

  2009cites this paper
• The diagnostic utility of cardiovascular magnetic resonance in patients with chest pain, elevated cardiac enzymes and non-obstructed coronary arteries.

  2009cites this paper
• Utilidad diagnóstica de la resonancia magnética cardiovascular en pacientes con dolor torácico, enzimas cardiacas elevadas y ausencia de obstrucción arterial coronaria

  2009cites this paper